outcome of the Board Meeting under Regulation 30 read with 33 (3) of SEBI (LODR) Regulation 2015
Vista Pharmaceuticals Ltd. Press Release Nov 13 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
Vista Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Nov 07 2024
- Board Meeting Intimation for For Approval Of Unaudited Financial Results For The Quarter Ended 30.09.2024
Later from Vista Pharmaceuticals
- Intimation Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015 - ''Issue Of World Health Organisation (WHO) G.M.P. Certificate.
- Vista Pharmaceuticals Ltd. Press Release Nov 14 2024
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Dec 29 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals